Trial
NCT03616470
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
GlycoMimetics Incorporated
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Uproleselan
Why stopped
Trial failed to meet primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-29